市場調査レポート

商品コード

1617163

中心静脈カテーテルの2030年までの市場予測：製品別、特性別、デザイン別、組成別、エンドユーザー別、地域別の世界分析

Central Venous Catheter Market Forecasts to 2030 - Global Analysis By Product (Tunneled Catheters and Non-Tunneled Catheters), Property, Design, Composition, End User and By Geography

出版日: 2024年12月11日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 634,784円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 803,040円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 971,296円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,147,200円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=152.96円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の中心静脈カテーテル市場は2024年に28億6,100万米ドルを占め、2030年には46億9,350万米ドルに達すると予測され、予測期間中のCAGRは8.6％です。

中心静脈カテーテル（CVC）は、薬剤、輸液、栄養剤の投与、血液サンプルの採取のために、頸部、胸部、鼠径部などの太い静脈に挿入される医療機器です。CVCは、重症患者や化学療法や透析などの長期治療を受けている患者によく使用されます。CVCは中心静脈系への長期的なアクセスを目的として設計されており、末梢静脈ラインに代わる安全な方法です。その使用には感染症や血栓症などのリスクが伴うため、慎重な管理が必要です。

世界保健機関（WHO）によると、毎年約3,000万人が敗血症と診断されています。

慢性疾患の増加

がん、心血管疾患、腎臓病などの慢性疾患の増加は、化学療法、透析、点滴などの長期治療を必要とすることが多く、CVCが重要な役割を果たします。世界人口の増加に伴い、こうした慢性疾患の罹患率も上昇し、需要をさらに押し上げています。さらに、より優れた安全性と効率を提供するCVC技術の進歩も、その採用拡大に寄与しています。ヘルスケアシステムはよりクリティカルケアに重点を置き、CVCの使用をさらに加速させています。患者数の増加と専門医療の必要性が相まって、市場の成長を後押ししています。

感染と合併症のリスク

カテーテル関連血流感染症（CRBSI）や血栓症などの感染症や合併症のリスクは、入院期間の延長、医療費の増加、患者の罹患率上昇につながります。そのため、ヘルスケアプロバイダーはCVCの使用に慎重であり、その結果、CVCの導入が制限される可能性があります。さらに、厳しい感染管理規制や専門的なトレーニングの必要性が、CVCの導入をさらに複雑にしています。安全性への懸念による製品回収も市場の信頼に悪影響を及ぼします。耐感染設計の革新にもかかわらず、これらのリスクは依然として大きな障壁となっています。

製品の革新

抗菌性コーティングなどの製品イノベーションは、感染リスクの低減に役立ち、CVCの使用に関連する主要な懸念事項の1つに対処します。さらに、より耐久性が高く使いやすいカテーテルの開発により、患者の転帰と医療従事者の満足度が向上しています。カテーテル材料の進歩により、柔軟性と生体適合性が向上したことも、長期使用に寄与しています。こうした技術革新は市場成長の原動力となるだけでなく、クリティカルケア現場における安全で効果的な医療機器に対する需要の高まりにも貢献しています。その結果、ヘルスケアプロバイダーは新技術を採用しやすくなり、市場はさらに拡大します。

コストとヘルスケア予算の制約

CVCデバイスとその挿入手順に関連する高コストが、特に低資源環境での採用を制限しています。病院の予算制約により、必要不可欠な治療が優先され、CVCのような先進医療機器への割り当てが減少する可能性があります。さらに、病院はより安価な代替品を選ぶ可能性があり、患者ケアの質を損なう可能性があります。コスト効率の高いソリューションとリソースの最適化に対するニーズの高まりが、CVC市場に圧力をかけています。特に新興市場の病院では、高品質のカテーテルを購入することが困難な場合があります。このため、より新しく効果的なCVC技術の採用が遅れる可能性があります。

COVID-19の影響

COVID-19の大流行は中心静脈カテーテル（CVC）市場に大きな影響を与え、サプライチェーンの混乱、選択的処置の遅延、COVID-19治療への医療優先順位の転換を招いた。このため、緊急でない医療処置の需要が減少し、病院でのCVC使用に影響が出ました。しかし、パンデミックは重症患者に対する重症治療や長期治療の必要性を高め、CVCの需要を生み出しました。パンデミック後のヘルスケアシステムの適応に伴い、市場は安全性と感染予防に再び焦点を当てながら回復しつつあります。

予測期間中、抗菌カテーテル分野が最大となる見込み

抗菌カテーテルセグメントは、従来のカテーテルに関連する感染リスクの増加により、有利な成長を遂げると推定されます。これらの特殊カテーテルは抗菌剤でコーティングされており、ヘルスケアプロバイダーにとって大きな関心事である感染の可能性を低減します。病院が患者の安全性向上を目指す中、抗菌CVCの需要が高まっています。さらに、これらのカテーテルはヘルスケア関連感染を減少させることで患者の転帰を改善し、最終的には治療費を削減します。抗菌コーティングの技術的進歩が市場の成長をさらに後押ししています。

専門クリニック分野は予測期間中に最も高いCAGRが見込まれる

専門クリニック分野は、がん、心血管疾患、腎臓疾患などの慢性疾患に焦点を絞った治療を提供することで、予測期間中に最も高いCAGR成長が見込まれます。これらのクリニックでは、化学療法や透析などのオーダーメイド治療が行われており、CVCは長期の投薬に不可欠です。このような疾患の有病率の増加は、専門的で継続的なケアに対する需要を煽り、CVCの使用を後押ししています。さらに、これらのクリニックには高度な設備と医療専門知識が備わっていることが多く、より安全なCVCの使用が保証されています。患者数の増加とヘルスケアインフラの改善により、専門クリニックは市場拡大を推進する主要セグメントとなっています。この動向は、特に新興市場でより多くの専門クリニックが出現するにつれて、今後も続くと予想されます。

最大のシェアを占める地域

アジア太平洋地域は、がん、心血管疾患、腎臓疾患などの慢性疾患の有病率の上昇に牽引され、予測期間中最大の市場シェアを占めると予測されます。中国、インド、日本などの国々では、専門クリニックやヘルスケア施設の数が増加しており、クリティカルケア治療へのアクセスが向上しているため、CVCの需要がさらに高まっています。さらに、ヘルスケア・インフラの改善と先進医療に対する意識の高まりが市場拡大を後押ししています。その結果、アジア太平洋地域は今後数年間、世界のCVC市場の成長に大きく貢献すると予想されます。

CAGRが最も高い地域：

北米は、がん、心血管疾患、腎臓疾患などの慢性疾患の有病率が高いことから、予測期間中、CAGRが最も高くなると予測されています。北米ではヘルスケアのインフラが発達し、専門クリニックや病院が増加していることもCVCの需要を押し上げています。さらに、感染リスクを低減し、患者の予後を改善するカテーテル設計の技術革新も市場を後押ししています。人口の高齢化と化学療法や透析などの長期治療の増加が、市場の拡大をさらに後押ししています。規制基準と確立されたヘルスケアシステムは、この成長軌道を維持すると予想されます。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品発売
事業拡大
その他の主要戦略

第12章企業プロファイリング

ICU Medical, Inc.
B. Braun SE
Becton, Dickinson and Company
Poly Medicure Ltd.
Lepu Medical Technology Co., Ltd.
Teleflex Incorporated
VOGT Medical
ZOLL Medical Corporation
EETA Surgical
QMD
Kimal
Medtronic
Rex Medical, LLC
Asahi Kasei Corporation
AngioDynamics, Inc.

図表

List of Tables

Table 1 Global Central Venous Catheter Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
Table 3 Global Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
Table 4 Global Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
Table 5 Global Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
Table 6 Global Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
Table 7 Global Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
Table 8 Global Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
Table 9 Global Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
Table 10 Global Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
Table 11 Global Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
Table 12 Global Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
Table 13 Global Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
Table 14 Global Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
Table 15 Global Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
Table 16 Global Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
Table 17 Global Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
Table 18 Global Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
Table 19 Global Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 20 Global Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
Table 21 Global Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
Table 22 Global Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
Table 23 North America Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
Table 24 North America Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
Table 25 North America Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
Table 26 North America Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
Table 27 North America Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
Table 28 North America Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
Table 29 North America Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
Table 30 North America Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
Table 31 North America Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
Table 32 North America Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
Table 33 North America Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
Table 34 North America Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
Table 35 North America Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
Table 36 North America Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
Table 37 North America Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
Table 38 North America Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
Table 39 North America Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
Table 40 North America Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
Table 41 North America Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 42 North America Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
Table 43 North America Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
Table 44 North America Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
Table 45 Europe Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
Table 46 Europe Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
Table 47 Europe Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
Table 48 Europe Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
Table 49 Europe Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
Table 50 Europe Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
Table 51 Europe Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
Table 52 Europe Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
Table 53 Europe Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
Table 54 Europe Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
Table 55 Europe Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
Table 56 Europe Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
Table 57 Europe Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
Table 58 Europe Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
Table 59 Europe Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
Table 60 Europe Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
Table 61 Europe Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
Table 62 Europe Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
Table 63 Europe Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 64 Europe Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
Table 65 Europe Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
Table 66 Europe Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
Table 67 Asia Pacific Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
Table 68 Asia Pacific Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
Table 69 Asia Pacific Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
Table 70 Asia Pacific Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
Table 71 Asia Pacific Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
Table 72 Asia Pacific Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
Table 73 Asia Pacific Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
Table 74 Asia Pacific Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
Table 75 Asia Pacific Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
Table 76 Asia Pacific Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
Table 77 Asia Pacific Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
Table 78 Asia Pacific Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
Table 79 Asia Pacific Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
Table 80 Asia Pacific Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
Table 81 Asia Pacific Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
Table 82 Asia Pacific Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
Table 83 Asia Pacific Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
Table 84 Asia Pacific Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
Table 85 Asia Pacific Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 86 Asia Pacific Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
Table 87 Asia Pacific Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
Table 88 Asia Pacific Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
Table 89 South America Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
Table 90 South America Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
Table 91 South America Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
Table 92 South America Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
Table 93 South America Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
Table 94 South America Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
Table 95 South America Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
Table 96 South America Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
Table 97 South America Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
Table 98 South America Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
Table 99 South America Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
Table 100 South America Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
Table 101 South America Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
Table 102 South America Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
Table 103 South America Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
Table 104 South America Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
Table 105 South America Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
Table 106 South America Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
Table 107 South America Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 108 South America Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
Table 109 South America Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
Table 110 South America Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
Table 111 Middle East & Africa Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
Table 112 Middle East & Africa Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
Table 113 Middle East & Africa Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
Table 114 Middle East & Africa Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
Table 115 Middle East & Africa Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
Table 116 Middle East & Africa Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
Table 117 Middle East & Africa Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
Table 118 Middle East & Africa Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
Table 119 Middle East & Africa Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
Table 120 Middle East & Africa Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
Table 121 Middle East & Africa Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
Table 122 Middle East & Africa Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
Table 123 Middle East & Africa Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
Table 124 Middle East & Africa Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
Table 125 Middle East & Africa Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
Table 126 Middle East & Africa Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
Table 127 Middle East & Africa Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
Table 128 Middle East & Africa Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
Table 129 Middle East & Africa Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 130 Middle East & Africa Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
Table 131 Middle East & Africa Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
Table 132 Middle East & Africa Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)

Product Code: SMRC28042

According to Stratistics MRC, the Global Central Venous Catheter Market is accounted for $2861.0 million in 2024 and is expected to reach $4693.5 million by 2030 growing at a CAGR of 8.6% during the forecast period. A Central Venous Catheter (CVC) is a medical device inserted into a large vein, often in the neck, chest, or groin, to deliver medications, fluids, or nutrients, or to collect blood samples. It is commonly used in critically ill patients or those undergoing prolonged treatments such as chemotherapy or dialysis. CVCs are designed for long-term access to the central venous system, offering a safer alternative to peripheral intravenous lines. Their use carries risks such as infection or thrombosis, requiring careful management.

According to the World Health Organization (WHO) approximately 30 million people are diagnosed every year with sepsis.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and kidney diseases, often require long-term treatment such as chemotherapy, dialysis, or intravenous medicine, where CVCs are crucial. As the global population increases, the incidence of these chronic conditions increases further boosts demand. Additionally, advancements in CVC technology, offering better safety and efficiency, have contributed to their growing adoption. Healthcare systems are focusing more on critical care, further accelerating the use of CVCs. The combination of higher patient volumes and the need for specialized medical care propels market growth.

Restraint:

Risk of infection and complications

The risk of infection and complications, such as catheter-related bloodstream infections (CRBSIs) and thrombosis, can lead to longer hospital stays, increased healthcare costs, and patient morbidity. As a result, healthcare providers are cautious about CVC usage, which may limit their adoption. Moreover, stringent infection control regulations and the need for specialized training further complicate CVC implementation. Product recalls due to safety concerns also negatively affect market confidence. Despite innovations in infection-resistant designs, these risks remain a significant barrier.

Opportunity:

Product innovation

Product innovation such as those with antimicrobial coatings, help reduce infection risks, addressing one of the major concerns associated with CVC use. Additionally, the development of more durable and user-friendly catheters has improved patient outcomes and healthcare provider satisfaction. Advances in catheter materials, making them more flexible and biocompatible, also contribute to longer-term usage. These innovations not only drive market growth but also help meet the increasing demand for safe, effective medical devices in critical care settings. As a result, healthcare providers are more likely to adopt new technologies, further expanding the market.

Threat:

Cost and healthcare budget constraints

High costs associated with CVC devices and their insertion procedures limit their adoption, especially in low-resource settings. Budget constraints in hospitals can lead to prioritization of essential treatments, reducing the allocation for advanced medical devices like CVCs. Additionally; hospitals may opt for cheaper alternatives, potentially compromising patient care quality. The increasing need for cost-efficient solutions and resource optimization adds pressure on the CVC market. Hospitals, particularly in emerging markets, may struggle with the affordability of high-quality catheters. This can slow down the adoption of newer, more effective CVC technologies.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the central venous catheter (CVC) market, leading to supply chain disruptions, delays in elective procedures, and a shift in healthcare priorities toward COVID-19 treatment. This reduced the demand for non-urgent medical procedures, affecting CVC usage in hospitals. However, the pandemic also increased the need for critical care and long-term treatments in severely ill patients, creating demand for CVCs. As the healthcare system adapts post-pandemic, the market is recovering with renewed focus on safety and infection prevention.

The antimicrobial catheters segment is expected to be the largest during the forecast period

The antimicrobial catheters segment is estimated to have a lucrative growth, due to the increasing risk of infections associated with traditional catheters. These specialized catheters are coated with antimicrobial agents that reduce the likelihood of infections, a major concern for healthcare providers. As hospitals aim to enhance patient safety, the demand for antimicrobial CVCs is rising. Additionally, these catheters improve patient outcomes by lowering healthcare-associated infections, which ultimately reduces treatment costs. Technological advancements in antimicrobial coatings further boost market growth.

The specialized clinics segment is expected to have the highest CAGR during the forecast period

The specialized clinics segment is anticipated to witness the highest CAGR growth during the forecast period, by offering focused care for chronic conditions like cancer, cardiovascular diseases, and kidney disorders. These clinics provide tailored treatments, including chemotherapy and dialysis, where CVCs are essential for long-term medication administration. The increased prevalence of such conditions fuels the demand for specialized, continuous care, boosting the use of CVCs. Furthermore, these clinics often have advanced facilities and medical expertise, ensuring safer CVC usage. With rising patient numbers and improved healthcare infrastructure, specialized clinics are a key segment propelling market expansion. This trend is expected to continue, particularly as more specialized clinics emerge in emerging markets.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period driven by the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and kidney disorders. The increasing number of specialized clinics and healthcare facilities in countries such as China, India, and Japan is enhancing access to critical care treatments, further boosting CVC demand. Additionally, improvements in healthcare infrastructure and rising awareness about advanced medical treatments are propelling market expansion. As a result, Asia-Pacific is expected to be a key contributor to the global CVC market's growth in the coming years.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the region's high prevalence of chronic diseases like cancer, cardiovascular disorders, and kidney conditions. Advanced healthcare infrastructure and the increasing number of specialized clinics and hospitals in North America also boost demand for CVCs. Additionally, technological innovations in catheter design, which reduce infection risks and improve patient outcomes, are propelling the market. The aging population and the growing number of long-term treatments, such as chemotherapy and dialysis, further support market expansion. Regulatory standards and a well-established healthcare system are expected to sustain this growth trajectory.

Key players in the market

Some of the key players profiled in the Central Venous Catheter Market include ICU Medical, Inc., B. Braun SE, Becton, Dickinson and Company, Poly Medicure Ltd., Lepu Medical Technology Co., Ltd., Teleflex Incorporated, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal, Medtronic, Rex Medical, LLC, Asahi Kasei Corporation and AngioDynamics, Inc.

Key Developments:

In November 2024, ICU Medical announced the creation of a joint venture with Otsuka Pharmaceutical Factory, Inc. This collaboration aims to enhance IV solutions manufacturing and innovation in North America.

In June 2024, B. Braun sold its global orthobiologics business, including TETEC AG in Germany and Aesculap Biologics LLC in the U.S., to Octane Medical Group. This transfer included products such as NOVOCART 3D and NOVOCART Inject, which are innovative cartilage repair solutions.

In May 2024, B. Braun introduced the Flexiva TractSeal Mini Fiber in May 2024. This innovative product is designed for minimally invasive laser lithotripsy, ensuring efficiency in urinary stone treatment. It highlights B. Braun's commitment to expanding its minimally invasive medical technologies portfolio.

Products Covered:

Tunneled Catheters
Non-Tunneled Catheters

Properties Covered:

Antimicrobial Catheters
Non-Antimicrobial Catheters

Designs Covered:

Single Lumen
Double Lumen
Multiple Lumen

Compositions Covered:

Polyurethane
Teflon
Silicone Rubber
Other Compositions

End Users Covered:

Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Cancer Research Institutes
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Central Venous Catheter Market, By Product

5.1 Introduction
5.2 Tunneled Catheters
5.3 Non-Tunneled Catheters

6 Global Central Venous Catheter Market, By Property

6.1 Introduction
6.2 Antimicrobial Catheters
6.3 Non-Antimicrobial Catheters

7 Global Central Venous Catheter Market, By Design

7.1 Introduction
7.2 Single Lumen
7.3 Double Lumen
7.4 Multiple Lumen

8 Global Central Venous Catheter Market, By Composition

8.1 Introduction
8.2 Polyurethane
8.3 Teflon
8.4 Silicone Rubber
8.5 Other Compositions

9 Global Central Venous Catheter Market, By End User

9.1 Introduction
9.2 Hospitals
9.3 Ambulatory Surgical Centers
9.4 Specialized Clinics
9.5 Cancer Research Institutes
9.6 Other End Users

10 Global Central Venous Catheter Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 ICU Medical, Inc.
12.2 B. Braun SE
12.3 Becton, Dickinson and Company
12.4 Poly Medicure Ltd.
12.5 Lepu Medical Technology Co., Ltd.
12.6 Teleflex Incorporated
12.7 VOGT Medical
12.8 ZOLL Medical Corporation
12.9 EETA Surgical
12.10 QMD
12.11 Kimal
12.12 Medtronic
12.12 Rex Medical, LLC
12.14 Asahi Kasei Corporation
12.15 AngioDynamics, Inc.

中心静脈カテーテルの2030年までの市場予測：製品別、特性別、デザイン別、組成別、エンドユーザー別、地域別の世界分析

Central Venous Catheter Market Forecasts to 2030 - Global Analysis By Product (Tunneled Catheters and Non-Tunneled Catheters), Property, Design, Composition, End User and By Geography

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の中心静脈カテーテル市場：製品別

第6章 世界の中心静脈カテーテル市場：特性別

第7章 世界の中心静脈カテーテル市場：デザイン別

第8章 世界の中心静脈カテーテル市場：組成別

第9章 世界の中心静脈カテーテル市場：エンドユーザー別

第10章 世界の中心静脈カテーテル市場：地域別

第11章 主な発展

第12章 企業プロファイリング